Brown Brothers Harriman & CO Mirum Pharmaceuticals, Inc. Transaction History
Brown Brothers Harriman & CO
- $13.6 Billion
- Q4 2024
A detailed history of Brown Brothers Harriman & CO transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 2,499 shares of MIRM stock, worth $98,935. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,499
Previous 2,499
-0.0%
Holding current value
$98,935
Previous $97,000
6.19%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$260 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$181 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$128 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$111 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$103 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.45B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...